Trials / Completed
CompletedNCT02273323
Flow Mediated Dilation in Response to Black Tea
Flow Mediated Dilation in Response to Consumption of Black Tea Versus Artificial Tea, in Non-tea Drinking Hypertensive Subjects.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Unilever R&D · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Research indicate that people who regularly drink tea have a reduced risk of stroke or heart disease. In a number of studies in which people that normally do not drink showed that their blood vessels function improved when the drunk tea. The current study tests whether a specific black tea improves vessel function in non-tea drinking hypertensive subjects.
Detailed description
Epidemiological studies indicate that regular consumption of three cups of black tea per day reduces the risk of stroke or myocardial infarction. In a number of previous nutrition intervention studies tea has been shown to improve vascular function as assessed by Flow Mediated Dilation in various populations. The current confirmatory study tests a specific black tea against a placebo in a population of in non-tea drinking hypertensive subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Tea | Single dose of black tea infusion containing approximately 400 mg flavonoids (expressed as gallic acid equivalents) with added sugar. |
| OTHER | Placebo | Placebo: tea flavour, colouring and sugar |
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2015-10-01
- Completion
- 2015-10-01
- First posted
- 2014-10-23
- Last updated
- 2017-02-15
- Results posted
- 2017-02-15
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02273323. Inclusion in this directory is not an endorsement.